| The role of angiogenesis in hepatocellular carcinoma MA Morse, W Sun, R Kim, AR He, PB Abada, M Mynderse, RS Finn Clinical Cancer Research 25 (3), 912-920, 2019 | 425 | 2019 |
| A phase 2 multi-institutional study of nivolumab for patients with advanced refractory biliary tract cancer RD Kim, V Chung, OB Alese, BF El-Rayes, D Li, TE Al-Toubah, MJ Schell, ... JAMA oncology 6 (6), 888-894, 2020 | 367 | 2020 |
| Hepatocellular carcinoma (HCC): beyond sorafenib—chemotherapy DW Kim, C Talati, R Kim Journal of gastrointestinal oncology 8 (2), 256, 2017 | 289 | 2017 |
| First-in-class, first-in-human phase I study of selinexor, a selective inhibitor of nuclear export, in patients with advanced solid tumors AR Abdul Razak, M Mau-Soerensen, NY Gabrail, JF Gerecitano, ... Journal of Clinical Oncology 34 (34), 4142-4150, 2016 | 223 | 2016 |
| First-in-human phase I study of fisogatinib (BLU-554) validates aberrant FGF19 signaling as a driver event in hepatocellular carcinoma RD Kim, D Sarker, T Meyer, T Yau, T Macarulla, JW Park, SP Choo, ... Cancer discovery 9 (12), 1696-1707, 2019 | 193 | 2019 |
| Etiology of Barrett's metaplasia and esophageal adenocarcinoma. R Kim, JL Weissfeld, JC Reynolds, LH Kuller Cancer epidemiology, biomarkers & prevention: a publication of the American …, 1997 | 149 | 1997 |
| A phase II study of RO4929097 in metastatic colorectal cancer JR Strosberg, T Yeatman, J Weber, D Coppola, MJ Schell, G Han, ... European journal of cancer 48 (7), 997-1003, 2012 | 140 | 2012 |
| Is there a role for second-line chemotherapy in advanced gastric cancer? R Wesolowski, C Lee, R Kim The lancet oncology 10 (9), 903-912, 2009 | 139 | 2009 |
| Minimally invasive surgical staging is superior to endoscopic ultrasound in detecting lymph node metastases in esophageal cancer JD Luketich, P Schauer, R Landreneau, N Nguyen, K Urso, P Ferson, ... The Journal of Thoracic and Cardiovascular Surgery 114 (5), 817-823, 1997 | 138 | 1997 |
| Sorafenib in advanced hepatocellular carcinoma: hypertension as a potential surrogate marker for efficacy B Estfan, M Byrne, R Kim American journal of clinical oncology 36 (4), 319-324, 2013 | 137 | 2013 |
| Comparative analysis of the safety and efficacy of transcatheter arterial chemoembolization and yttrium-90 radioembolization in patients with unresectable hepatocellular carcinoma C Lance, G McLennan, N Obuchowski, G Cheah, A Levitin, M Sands, ... Journal of Vascular and Interventional Radiology 22 (12), 1697-1705, 2011 | 113 | 2011 |
| Randomized phase II study of axitinib versus placebo plus best supportive care in second-line treatment of advanced hepatocellular carcinoma YK Kang, T Yau, JW Park, HY Lim, TY Lee, S Obi, SL Chan, SK Qin, ... Annals of Oncology 26 (12), 2457-2463, 2015 | 104 | 2015 |
| Expression of p53, PCNA, and C-erbB-2 in Barrett's metaplasia and adenocarcinoma MA Young, MM Vanbibber, AV Safatle-Ribeiro, R Kim, MR Clarke, ... Digestive diseases and sciences 42, 2453-2462, 1997 | 98 | 1997 |
| Adjuvant therapy for resected extrahepatic cholangiocarcinoma: a review of the literature and future directions C Anderson, R Kim Cancer treatment reviews 35 (4), 322-327, 2009 | 89 | 2009 |
| Acquired on-target clinical resistance validates FGFR4 as a driver of hepatocellular carcinoma MA Hatlen, O Schmidt-Kittler, CA Sherwin, E Rozsahegyi, N Rubin, ... Cancer discovery 9 (12), 1686-1695, 2019 | 86 | 2019 |
| Prognostic roles of human equilibrative transporter 1 (hENT‐1) and ribonucleoside reductase subunit M1 (RRM1) in resected pancreatic cancer R Kim, A Tan, KK Lai, J Jiang, Y Wang, LA Rybicki, X Liu Cancer 117 (14), 3126-3134, 2011 | 73 | 2011 |
| Intra-axial tumors of the cervicomedullary junction: surgical results and long-term outcome HL Weiner, D Freed, H Woo, AR Rezai, R Kim, FJ Epstein Pediatric neurosurgery 27 (1), 12-18, 1997 | 72 | 1997 |
| Intrahepatic cholangiocarcinoma treated with transarterial yttrium-90 glass microsphere radioembolization: results of a single institution retrospective study A Gangi, J Shah, N Hatfield, J Smith, J Sweeney, J Choi, G El-Haddad, ... Journal of Vascular and Interventional Radiology 29 (8), 1101-1108, 2018 | 70 | 2018 |
| Co-evolution of somatic variation in primary and metastatic colorectal cancer may expand biopsy indications in the molecular era R Kim, MJ Schell, JK Teer, DM Greenawalt, M Yang, TJ Yeatman PLoS One 10 (5), e0126670, 2015 | 70 | 2015 |
| Third-or later-line therapy for metastatic colorectal cancer: reviewing best practice T Bekaii-Saab, R Kim, TW Kim, JM O’Connor, JH Strickler, D Malka, ... Clinical colorectal cancer 18 (1), e117-e129, 2019 | 68 | 2019 |
